0374072015 1bD:38 Fron: EE Yoodson C. Merrell M Webfax Page: 6711 Specimen ID: 257-480-2371-0 Control ID: F5B31143092 Date collected: 09/14/2018 1255 Local DOB: 01/20/1953 TTY Patient: EPSTEIN, JEFFREY DEEA-Sulfate 181.8 ug/dL 30.9 - 295.6 01 Estradiol 28.3 pg/mL 7.6 - 42.6 01 Roche ECLIA methodology Uric Acid Uric Acid 6.8 mg/dL 3.7 - 6.6 01 Please Note: 01 Therapeutic target for gout patients: <6.0 Phosphorus 3.6 mg/dL 2.5 - 4.5 01 LDE 213 Iu/L 121 - 224 o1 GGT 25 Iu/L 0 - 65 02 Amylase 37 U/L 31 - 124 01 Ferritin, Serum Will Follow Insulin 47.2 High ulU/mL 2.6 - 24.9 o1 Calcium, Ionized, Serum 5.3 mg/dL 4.5 - 5.6 01 Pibrinogen Activity 330 mg/dL 193 - 507 01 Specimen was ultracentrifuged before testing to remove extreme lipemia. Results should be be interpreted with caution. Magnesium, RBC 5.4 mg/dL 4.2 - 6.8 02 Plasma NOT separated from cells; may falsely decrease RBC Macnesium levels. Date Issued: 09/18/18 1053 ET PRELIMINARY REPORT Page Sof 5 This document contains private and confidential health information protected by state and federal law. © 1995-2018 Laboratory Corporation of America® Holdings lf you have received this document in error, please call 800-431-5250 All Rights Reserved - Enterprise Report Version: 1.00 EFTA00314043